Catalyst Wire Dossier Catalyst Wire Dossier

RHOPRESSA

NETARSUDIL · Alcon Laboratories, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for RHOPRESSA, covering 2017-12-18 to 2025-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost [Phase 4]

See pricing